Emily Zediker, OD
Optometrist in San Antonio, Texas. This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers — including 60,463 in Optometrist, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration — see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Emily Zediker, OD reported a CMS MIPS final score of 70.7/100 — below the 83.1 national average — and filed 487 Medicare Part D claims in 2023.
- 70.7/100
- MIPS score · -12 vs avg
- 487
- Part D claims, 2023
- 60%
- generic prescribing
- $96.6
- industry payments (Sunshine Act)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
Emily Zediker, OD's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure
71 8th percentile higher than 8% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Emily Zediker, OD sits
This provider among optometrist peers
Across the 6,527 optometrist providers who report both Medicare Part D prescribing and a MIPS quality score, Emily Zediker, OD writes more Part D claims than 61% of them and scores higher on MIPS quality than 16% — placing this provider in the high-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one optometrist peer from a representative sample of 60; the gold marker is Emily Zediker, OD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
What does the federal data show about Emily Zediker, OD?
Below national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Texas
How Optometrist compares to other specialties among Texas providers
Largest specialties in Texas (% of in-state providers)
Optometrist ranks #24 among Texas's specialties (1.1% of in-state providers)
Each bar is a specialty's share of the Texas provider total, by primary NUCC taxonomy. The highlighted bar is Optometrist; the long tail of smaller specialties is omitted for legibility.
Medicare quality performance — MIPS
Emily Zediker, OD's 2023 MIPS final score plotted against the Optometrist national average
- MIPS Final Score
- 70.7/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Optometrist) — 70.7/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Cost dim CMS Cost category
- Specialty volume Optometrist US NPIs
70.7/100 MIPS final score — 12.4 pts below the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Optometrist. Quality dim: 88.4. Cost dim: 97.2.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Emily Zediker, OD appears in the CMS NPPES registry as a Optometrist provider holding OD credentials at 800 MCCULLOUGH AVE, San Antonio, TX, 78215, with a listed phone of (210) 226-6169. NPI 1790349074 was issued on 04/23/2019. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what Zediker most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 487 prescription claims written by this provider, covering 219 Medicare beneficiaries and totaling roughly $50K in drug spend, split 40% brand-name and 60% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 70.7/100 for the 2023 performance year (Quality 88.4, Cost 97.2), compared with the national average of 83.1.
Optometrist is a high-volume specialty nationwide, with 60,463 enrolled providers across 56 states and an average of 257 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1790349074 |
|---|---|
| Specialty | Optometrist |
| Credentials | OD |
| Gender | Female |
| NPI Issued | 04/23/2019 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Emily Zediker, OD's current license status, disciplinary history, and board certifications with the Texas Medical Board in Texas before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
Hospital and facility affiliations
Facilities where Emily Zediker, OD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Emily Zediker, OD. Source: openpaymentsdata.cms.gov.
Total received
$97
Largest payer
Tarsus Pharmaceuticals, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context — Texas TMB 2023 annual report
Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 — they are NOT specific to Emily Zediker, OD. To verify Emily Zediker, OD's current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Above average
40% brand-name claims vs 60% generic, on 487 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 934
- Total Day Supply
- 25,475
- Brand vs Generic
- 40% brand / 60% generic
- Brand Drug Cost
- $43K
- Generic Drug Cost
- $7K
- Antibiotic Claims
- 27
Patient Demographics
- Average Patient Age
- 74.3 years
- Avg HCC Risk Score
- 1.47
- Gender Split
- 63% female / 37% male
- Age Distribution
- <65: 18, 65-74: 96, 75-84: 79, 85+: 26
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Emily Zediker, OD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Latanoprost
Latanoprost
151 claims
- Prednisolone Acetate
Prednisolone Acetate
77 claims
- Timolol Maleate
Timolol Maleate
65 claims
- Neomycin-Polymyxin… 27
Neomycin-Polymyxin-Dexameth
27 claims
- Erythromycin 21
Erythromycin
21 claims
- Dorzolamide-Timolol 19
Dorzolamide-Timolol
19 claims
- Brimonidine Tartrate 17
Brimonidine Tartrate
17 claims
- Lumigan 13
Lumigan
13 claims
| Drug | Claims |
|---|---|
| Latanoprost | 151 |
| Prednisolone Acetate | 77 |
| Timolol Maleate | 65 |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 27 |
| Erythromycin Erythromycin Base | 21 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 19 |
| Brimonidine Tartrate | 17 |
| Lumigan Bimatoprost | 13 |
| Cephalexin | 12 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Optometrist Overview
How Emily Zediker, OD fits within the Optometrist landscape nationally.
Emily Zediker, OD's 487 claims are above the specialty average of 257.
Nearby Optometrist Providers in Texas
Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as Zediker.
Compare Optometrist nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry — providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Texas medical board — federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Optometrist peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only — they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Texas
Frequently Asked Questions
What is Emily Zediker, OD's specialty? ▼
How much does Emily Zediker, OD prescribe under Medicare Part D? ▼
What is Emily Zediker, OD's Medicare quality score? ▼
Where is Emily Zediker, OD located? ▼
What is Emily Zediker, OD's NPI number? ▼
Does Emily Zediker, OD prescribe more brand-name or generic drugs? ▼
How many Optometrist providers are there in the US? ▼
What drugs does Emily Zediker, OD prescribe most often? ▼
Does Emily Zediker, OD accept Medicare? ▼
How can I verify Emily Zediker, OD's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology